products

Thoracent

Minimally invasive devices for managing pleural effusions, restoring airway patency, and improving quality of life, along with an expanded suite of GI tools.

Learn more about Thoracent

Diagnostics

Developing molecular diagnostics to triage patients and ensure they get fast and effective care when they need it.

Learn more about Diagnostics

Biopsy Tools

Developing a suite of steerable endobronchial instruments to target difficult-to-reach off-airway nodules.

Learn more about our Biopsy Tools
View all product lines
>>
team

Leadership

Maverix leadership combines decades of clinical, technical, and operating experience.

Learn more about our leadership

Advisors

The Maverix Medical Advisory Board is comprised of leading pulmonary physicians.

Meet our advisors

Partners

Maverix collaborates with firms that are transforming medtech innovation.

See our partners
Meet the whole team
>>
news
Most Recent Article
Fierce Biotech
March 29, 2024

Lung Cancer Startup Maverix Medical Snaps Up Diagnostic Developer Cirrus Bio

Read More
PR Newswire
March 29, 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Read More
Wall Street Journal
November 30, 2023
Startup Ajax Health Extends Medtech Innovation Model to Hologic
Read More
Read all news
See all the news
>>
Contact
careers
menu
Close
Revolutionizing

Lung Cancer Care

Advancing detection.
Improving care.
Saving lives.

The
Challenge

Lung cancer is the deadliest cancer worldwide—more than colon, breast, and prostate cancer combined 1

16%

of eligible individuals are up to date with lung cancer screening1,2

28.1%

of cases are diagnosed when cancer still localized and survival rates are higher3

20.9%

of cases did not receive any treatment after diagnosis4
20%
of all cancer deaths
2.5M
new patients diagnosed globally every year

>66%

of eligible individuals are up to date with colorectal, breast, cervical cancer screenings1,2

27.5%

of patients currently survive longer than five years3

10-20%

of lung cancers are not caused by smoking5

The Maverix Solution

A portfolio focused on lung cancer diagnostics and devices to address the full spectrum of care.

Traditional Lung CanceR Patient Journey
Starts later, has longer therapy cycles and shorter life expectancy
Screening
Diagnosis
Treatment
Life Expectancy
Screening
Diagnosis
Treatment
Life Expectancy
Earlier diagnosis, shorter time to treatment, improved outcomes
Maverix Lung Cancer Patient Journey
Maverix
Screening
Maverix
Diagnosis
Maverix
Treatment

More Effective Screening

Lung cancer is a heterogeneous disease that can be challenging to diagnose. Our blood-based diagnostics enable early and accurate stratification of patients with nodules to triage and treat those who are really at high risk, complementing low-dose computed tomography (CT).

Learn more about our diagnostic innovations

More Accurate Biopsies

Improved CT screening programs are picking up smaller, off-airway nodules that are difficult to access with standard biopsy tools. Our advanced biopsy products, designed for use through the bronchoscope, enable higher yield and greater articulation for these "last-mile" cases, which drive early detection and streamline the continuum of care for lung cancer patients.

Learn more about our biopsy tools

Superior Treatment & Palliative Care

Lung cancer and its treatment can significantly impact physical function, impeding a patient’s ability to perform daily activities. By effectively managing the range of symptoms, our minimally invasive palliative care devices enhance well-being and overall quality of care for the millions of patients diagnosed after Stage I.

Learn more about our Thoracent products

Copyright © Maverix

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

textAlign-center
textAlign-left
textAlign-right
text-allcaps
text-italic
textSize-xxs
textSize-xs
textSize-s
textSize-m
textColor-white
textColor-midnight
textColor-cyan
textColor-blue
textSize-L
textSize-xL
textSize-xxL
textSize-xxxL
bgColor-midnight
bgColor-darkblue
bgColor-teal
bgColor-blue
bgColor-cyan
bgColor-lightblue
bgColor-white
bgColor-off-white
bgColor-dark-off-white